New research suggests that mail-order pharmacies may help stroke survivors take their meds.
Where possible, executives may want to encourage the use of mail-order pharmacy for patients who have experienced a stroke, a new study suggests.
Research compiled by a Medical University of South Carolina expert shows that using mail-order pharmacies may help stroke patients adhere to their medication regimens.
Bruce Ovbiagele, MD, of the Medical University of South Carolina in Charleston and the International Stroke Conference, analyzed data from Kaiser Permanente. The researchers looked at the prescr
Ovbiageleiption refill records of patients discharged with ischemic stroke and who were prescribed anticoagulant and cholesterol-lowering drugs between 2006 and 2015.
They found that 73.9% of prescriptions for statins and anticoagulants were refilled when patients used mail-order pharmacies compared to 46.5% through local pharmacies.
“[Mail-order pharmacies] seem to be associated with greater long-term medication adherence on the part of patients, and indirectly-although not proven yet-might be associated with better clinical outcomes and lower costs,” says Ovbiagele.
Stroke patients are at high risk for repeat strokes which often cause further disability, longer hospital stays, and higher likelihood of chronic institutionalization, according to Ovbiagele.
“So outcomes after a repeat stroke are often worse than after a first-time stroke, with a correspondingly higher cost of management,” he says. “Enhancing adherence to medications proven to prevent repeat strokes from occurring could avert additional disability or even death in these patients, as well as greatly reduce costs.”
Overall, mail-order pharmacy is a reasonable strategy for many types of patients “given the convenience of having the drug delivered to the home, which just makes it easier to ensure a patient does not forget or have to go out of his/her way to pick up the medication every time they are about to run out,” Ovbiagele says. “However, stroke patients can be especially vulnerable to suboptimal medication adherence with the typical pick from the local pharmacy because many stroke patients have lingering challenges with memory or ambulation such that having to always remember to pick up the medications directly from the pharmacy or relying on others to regularly help pick up the medications can be problematic.”
Apart from the novel anticoagulant medications for preventing strokes due to atrial fibrillation, most of the drugs used for preventing repeat strokes are generic or are not cost-prohibitive, according to Ovbiagele.
“Moreover, the monies spent on stroke patients adhering to any of these medications-including the novel anticoagulants-in a sustained manner should be well worth it, given the tremendous expense associated with the occurrence of repeat strokes,” he says.
David Calabrese of OptumRx Talks New Role, Market Insulin Prices and Other Topics 'On His Mind'
April 13th 2023In this month’s episode of the "What's On Your Mind podcast," Peter Wehrwein, managing editor of MHE connects with the now Chief Clinical Officer of OptumRx Integrated Pharmacies, David Calabrese. In this conversation, David touches on his transition in January as OptumRx’s former chief pharmacy officer and market president of health plans and PBMs to his new role as Chief Clinical Officer where he now focuses more on things such as specialty pharmacy to home delivery — with an overall goal of creating whole-patient care. Throughout the conversation, Calabrese also touched on the market’s hot topic of insulin prices and behavioral health services within the OptumRx community, among other topics.
Listen
Upended: Can PBM Transparency Succeed?
March 6th 2024Simmering tensions in the pharmacy benefit management (PBM) industry have turned into fault lines. The PBMs challenging the "big three" have formed a trade association. Purchaser coalitions want change. The head of the industry's trade group says inherent marketplace friction has spilled over into political friction.
Read More
Briana Contreras, editor of Managed Healthcare Executive, spoke with Nancy Lurker, CEO and president of EyePoint Pharmaceuticals. Nancy shared a bit about EyePoint and how the organization’s innovative therapies are addressing patient needs through eye care, and most importantly, she addressed C-Suite positions like the CEO role. Nancy shared advice for those seeking to reach the CEO level, especially toward women in healthcare and other roles, and what it takes to run a biopharma company.
Listen
The deliberate disconnection of Change Healthcare to ring fence a cyberattack entered its seventh day today. Prescribers are finding ways to get pharmacy claims processed, and UnitedHealth Group says disruption to the dispensing of prescriptions has been minimal. But independent pharmacies want more information and protection from financial consequences from pharmacy benefit managers.
Read More